Characteristics and prognosis of rrDLBCL with TP53 mutations and a high‐risk subgroup represented by the co‐mutations of DDX3X‐TP53

BACKGROUND: TP53 mutations have a prognostic significance in relapsed and refractory diffuse large B‐cell lymphoma (rrDLBCL) patients, and their treatment still faces a great challenge. This study aimed to evaluate the prognosis of patients with TP53 mutations (TP53mut) in the context of CAR‐T thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fan, Hu, Kai, Zheng, Peihao, Shi, Hui, Ke, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225230/
https://www.ncbi.nlm.nih.gov/pubmed/36971051
http://dx.doi.org/10.1002/cam4.5756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225230/
https://www.ncbi.nlm.nih.gov/pubmed/36971051
http://dx.doi.org/10.1002/cam4.5756

Ejemplares similares